COVID-19 Interim User Guide Task Force

Name Organization
Jennifer Alf Astellas
Rebecca Baker CDISC
Cathy Bezek Astellas
Dana Booth CDISC
Assia Bouhadouza Sanofi
Stephanie Chen AstraZeneca
Karen Fanouillere Sanofi
Nikki Flores Gilead Sciences
Nate Freimark The Griesser Group
Praveen Garg  AstraZeneca
Tom Guinter Nurocor
Ajay Gupta PPD
Brian Harris AstraZeneca
Keith Hibbetts Eli Lilly and Company
Kit Howard CDISC
Chris Kaiser Eli Lilly and Company
Smitha Karra Gilead Sciences
Kalynn Kennon Infectious Diseases Data Observatory (IDDO), University of Oxford, United Kingdom
Bess LeRoy CDISC
Laura Merson Infectious Diseases Data Observatory (IDDO), University of Oxford, United Kingdom
Erin Muhlbradt Medical Science and Computing, LLC & Contractor to the US National Cancer Institute’s Enterprise Vocabulary Services
Jon Neville CDISC
Amy Palmer CDISC
David Parkinson J&J (Janssen Pharmaceuticals)
Nik Pemble J&J (Janssen Pharmaceuticals)
Chris Price Roche
Heather Ribaudo Harvard – Center for Biostatistics in AIDS Research
Justin Ritz Harvard – Center for Biostatistics in AIDS Research
Lauren Shinaberry AbbVie
Trisha Simpson UCB
Lorraine P. Spencer AbbVie
Will Stevens Nuffield Department of Population Health, University of Oxford
Alana St. Clair CDISC
Sarah Strobino  Frontier Science Foundation
Helena Sviglin US Food and Drug Administration
Peter Van Reusel CDISC
Robin White Eli Lilly and Company
Diane Wold CDISC
Jennifer Xio National Institute of Allergy and Infectious Diseases (NIAID)